Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut: Understanding Infection and Coinfection Risks in a Nonurban Population | Zendy

Hana Akselrod | Zendy; Lauretta E. Grau | Zendy; Russell Barbour | Zendy; Robert Heimer | Zendy

Open Access

Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut: Understanding Infection and Coinfection Risks in a Nonurban Population

Author(s) -

Hana Akselrod,

Lauretta E. Grau,

Russell Barbour,

Robert Heimer

Publication year - 2013

Publication title -

american journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.284

H-Index - 264

eISSN - 1541-0048

pISSN - 0090-0036

DOI - 10.2105/ajph.2013.301357

Subject(s) - coinfection , medicine , seroprevalence , population , substance abuse , hepatitis c , hepatitis b virus , immunology , virology , psychiatry , environmental health , serology , human immunodeficiency virus (hiv) , virus , antibody

We examined HIV, hepatitis B virus (HBV), and HCV seroprevalence in an interim analysis and the potential risk factors associated with these infections among injection drug users (IDUs) residing in nonurban communities of southwestern Connecticut.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research